A phase 3 rheumatoid arthritis trial of Lynk Pharmaceuticals’ JAK1 inhibitor in China has hit its primary endpoint, boosting ...

Rheumatoid arthritis affects 1 in 100 people worldwide. It causes inflamed, painful and swollen joints, often in the hands and wrists, and can lead to loss of joint function as well as chronic pain ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Receiving a RA diagnosis from your doctor can be scary, stressful, and overwhelming. Your mind is full of questions and you're not sure where to begin. PEOPLE talked to rheumatologists to find out ...

Managing symptoms of rheumatoid arthritis may require trying different medicines to see what works best for you and your symptoms. The approval of Xeljanz has led to changes in how rheumatoid ...

People with rheumatoid arthritis face a higher risk of developing heart disease and heart failure due to chronic inflammation affecting heart function. Monitoring heart symptoms like chest pain and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Adults with rheumatoid arthritis are 23% ...

New research may lead to new targeted treatments for rheumatoid arthritis (RA), an autoimmune disease that causes joint inflammation and destruction. New research led by University of Colorado School ...

Millions of Americans are now taking GLP-1 medications, and the drugs are affecting their lives in about as many ways — far beyond the numbers on the scale. (Photo illustration: Yahoo News; photos: ...

Rheumatoid arthritis (RA) can lead to a metabolic state called rheumatoid cachexia, or muscle wasting. This form of cachexia happens when your body loses muscle mass and keeps fat mass. Your body ...